Breaking News

Cholesterolosis of the Gall Bladder - A Common Gall Bladder Disorder

Cholesterolosis is a common affection of the biliary system, characterized by the accumulation and deposition of cholesterol in the gall bladder and mucous membranes. Cholesterolosis usually occurs due to chemical imbalances at the level of the biliary system and these disorders are rarely associated with high levels of serum cholesterol, diabetes or atherosclerosis. Cholesterolosis generally occurs in the premise of abnormal activity of the gall bladder and changes in bile composition, facilitating the deposition of cholesterol in the gall bladder and bile ducts. Without proper treatment, cholesterolosis can lead to serious complications, including gall bladder cancer.

Although these types of bile disorders can occur in both sexes, cholesterolosis usually affects women. Also, cholesterolosis has the highest incidence in people over the age of 50. Most patients with cholesterolosis are asymptomatic, rarely experiencing symptoms such as diarrhea or diarrhea. Although these disorders can be treated early, advanced forms of cholesterolosis require surgical intervention. Medical reports show that cholesterol is responsible for more than 50 percent of cholecystectomies (surgical procedures involving the removal of diseased gall bladder).

Cholesterolosis can affect the gall bladder locally or generally. A common form of cholesterolosis is inflammation of the gastric mucosa, confirmed by the yellow staining of the gall bladder and membranes (due to fat deposition). The local form of cholesterolosis is characterized by the formation of small polyps, soft words that appear from the inner wall of the gall bladder. The size of this polyp varies from 1 to 10 mm.

Cholesterolosis can only be revealed by modern scanning techniques such as ultrasound imaging. Ultrasound tests can quickly uncover the presence of polyps and lipid masses associated with cholesterolosis. Polyp appears as a sticky adhesive to the mucous wall of the bile. This significant presence rarely involves hardening or thickening of the bile inner membrane. Patients who present with smaller polyps usually receive treatment to resolve this problem. However, the presence of larger polyps often involves colististectomy. Patients with bile duct problems may also receive biopsy before surgery. Although bile duct polyps are usually benign, cholesterolosis can also cause malignant activity at the biliary system level.

Similar to cholesterolosis, adenomyomatosis is a disorder that can also cause malignant cellular activity at the gallbladder level. Unlike most forms of cholesterolosis, adenomyomatosis is characterized by thickening of the gall bladder wall. To distinguish between the two disorders, doctors usually examine the integrity and general aspects of the gall bladder before deciding on a final diagnosis. Speed ​​is important in diagnosing and treating bile disorders such as cholesterolosis and adenomyomatosis, as both of these feelings can lead to violence. Rapid medical intervention can easily make the difference between complete and partial recovery exposing patients to high risk of malignant disease.


No comments